Paliperidone Palmitate Stada

Paliperidone, the active ingredient in Paliperidone Palmitate Stada, is a atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is indicated for the treatment of schizophrenia in adult patients. GNH USA supplies Paliperidone Palmitate Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Paliperidone Palmitate Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidone Palmitate is an atypical antipsychotic that works within the dopamine‑serotonin pathway to manage psychotic disorders.

- Schizophrenia: Improves positive and negative symptoms and reduces risk of relapse. - Schizoaffective disorder: Stabilises mood symptoms and psychotic features. - Maintenance therapy for schizophrenia: Provides sustained symptom control with monthly dosing.

Common Side Effects: - Ak Ak   -            ... ... ...    ...  ...  ....  ... …  …  ....  .... … ... ... …  … … … … … ...  g -  ... … ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 

Serious or Rare Side Effects: -  ....  …  ... … … … … -  ... "); }